The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of KROS 101, a small molecule GITR ligand agonist, on T effector cells, T reg cells and intratumoral CD8 T cell cytotoxicity.
 
John Yu
Employment - Kairos Pharma
Leadership - Kairos Pharma
Stock and Other Ownership Interests - Kairos Pharma
Patents, Royalties, Other Intellectual Property - Kairos Pharma
 
Tesfahun Admasu
No Relationships to Disclose
 
Hongqiang Wang
No Relationships to Disclose
 
Woo Kim
No Relationships to Disclose
 
Aida Pirvaram
No Relationships to Disclose
 
Kalyane Dnyaneshwar
No Relationships to Disclose
 
Seokyoung Yoon
No Relationships to Disclose
 
Ramachandran Murali
Employment - Kairos Pharma
Leadership - Kairos Pharma
Stock and Other Ownership Interests - Kairos Pharma